Orthofix Medical Inc. (OFIX) has a negative trailing P/E of -5.3, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -18.93%.
Criteria proven by this page:
Overall SharesGrow Score: 46/100 with 1/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2016 | 214.8 | -1.01 | 2.49 | 1.60 | - |
| 2017 | 159.3 | 1.59 | 3.34 | 2.28 | - |
| 2018 | 70.3 | 0.58 | 2.89 | 2.14 | - |
| 2019 | -30.7 | 0.10 | 2.66 | 1.90 | - |
| 2020 | 329.0 | -3.03 | 2.32 | 2.04 | - |
| 2021 | -16.0 | 0.01 | 1.82 | 1.32 | - |
| 2022 | -20.9 | 0.42 | 1.22 | 0.90 | - |
| 2023 | -3.3 | -0.01 | 0.83 | 0.66 | - |
| 2024 | -5.3 | 0.27 | 1.32 | 0.83 | - |
| 2025 | -6.6 | 0.21 | 1.34 | 0.74 | - |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2016 | $0.17 | $409.79M | $3.06M | 0.7% |
| 2017 | $0.34 | $433.82M | $6.22M | 1.4% |
| 2018 | $0.73 | $453.04M | $13.81M | 3% |
| 2019 | $-1.51 | $459.96M | $-28.46M | -6.2% |
| 2020 | $0.13 | $406.56M | $2.52M | 0.6% |
| 2021 | $-1.95 | $464.48M | $-38.38M | -8.3% |
| 2022 | $-0.98 | $460.71M | $-19.75M | -4.3% |
| 2023 | $-4.12 | $746.64M | $-151.4M | -20.3% |
| 2024 | $-3.30 | $799.49M | $-126M | -15.8% |
| 2025 | $-2.28 | $822.31M | $-92.19M | -11.2% |
| Year | EPS (Avg) | EPS Range | Revenue (Avg) | Revenue Range | Analysts |
|---|---|---|---|---|---|
| 2026 | $-1.31 | $-1.31 – $-1.31 | $855.92M | $854.75M – $856.97M | 1 |
| 2027 | $-0.64 | $-0.64 – $-0.64 | $909.17M | $908.06M – $909.78M | 1 |
| 2028 | $-0.59 | $-0.59 – $-0.59 | $962.86M | $961.05M – $964.67M | 1 |
| 2029 | $0.00 | $0.00 – $0.00 | $1.03B | $1.03B – $1.03B | 0 |
| 2030 | $0.00 | $0.00 – $0.00 | $1.09B | $1.08B – $1.09B | 0 |
